𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Juvenile onset Huntington's disease?clinical and research perspectives

✍ Scribed by Nance, Martha A. ;Myers, Richard H.


Publisher
John Wiley and Sons
Year
2001
Tongue
English
Weight
124 KB
Volume
7
Category
Article
ISSN
1080-4013

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Huntington's disease (HD) is an inherited neurodegenerative disorder. The mutation which causes the disease is an expansion in the number of repetitions of three nucleotides, C, A, and G in exon 1 of the huntingtin gene. The gene normally has 15 to 30 repeats and an expansion to 40 or more is associated with HD. HD usually has a mid‐life onset, but a juvenile form, defined by onset of symptoms before the age of 21 years, is present in about 7% of HD cases. Juvenile HD is characterized by (1) transmission from an HD affected father, (2) an unusually large repeat size, usually of 60 or more units, and (3) unique clinical features, including rigidity and seizure disorder. Although juvenile onset is associated with a more severe neuropathological involvement, the neuropathological characteristics of juvenile HD are similar to those seen in the adult form in that the striatum bears the brunt of the illness. Clumps of protein, termed inclusion bodies, which stain positive for huntingtin and ubiquitin, are found primarily in the nucleus but also in the cytoplasm and axons in HD neurons. Research suggests that these inclusion bodies sequester a deleterious protein fragment and prolong cell life during the degenerative process of the disease. MRDD Research Reviews 2001;7:153–157. Β© 2001 Wiley‐Liss, Inc.


πŸ“œ SIMILAR VOLUMES


Dystonia in Huntington's disease: Preval
✍ Elan D. Louis; Peter Lee; Lori Quinn; Karen Marder πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 43 KB πŸ‘ 2 views

## Background: The prevalence and clinical characteristics of dystonia in huntington's disease (hd) have not been formally assessed. ## Objectives: To study (1) the prevalence of dystonia in hd in a clinic population, (2) the clinical features of dystonia, and (3) clinical correlates of dystonia

Huntington's disease phenocopies are cli
✍ Edward J. Wild; Ese E. Mudanohwo; Mary G. Sweeney; Susanne A. Schneider; Jon Bec πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 61 KB

## Abstract Huntington's disease (HD) classically presents with movement disorder, cognitive dysfunction and behavioral problems but is phenotypically variable. One percent of patients with HD‐like symptoms lack the causative mutation and are considered HD phenocopies. Genetic diseases known to cau

Clinical and genetic characteristics of
✍ MarΓ­a Elisa Alonso; Adriana Ochoa; Marie-Catherine Boll; Ana Luisa Sosa; Petra Y πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 348 KB

## Abstract We report the characteristics of 691 Mexican patients with Huntington's disease (HD). These patients, representing 401 families, constitute the largest series of Mexican HD cases as yet described in the literature. We found the clinical characteristics of these patients to be similar to

The current clinical management of Hunti
✍ Wendy Phillips; Kathleen M. Shannon; Roger A. Barker πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 225 KB

## Abstract Huntington's disease is a neurodegenerative condition, characterized by movement disorders, cognitive decline, and psychiatric disturbance. We review the pharmacological management of the various movement disorders associated with the disease, the cognitive decline and the commonly enco